Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
Not Applicable
Completed
- Conditions
- Benign Prostatic Hypertrophy With Outflow ObstructionOveractive Detrusor
- Interventions
- Procedure: Holmium Laser Enucleation of the Prostate (HoLEP)Device: Holmium laser enucleation system and morcellator
- First Posted Date
- 2013-01-31
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- KYU-SUNG LEE
- Target Recruit Count
- 184
- Registration Number
- NCT01781117
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Extracorporeal Biofeedback
Not Applicable
Completed
- Conditions
- Female Stress Urinary Incontinence
- Interventions
- Device: PFMT with Extracorporeal Biofeedback
- First Posted Date
- 2009-05-29
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- KYU-SUNG LEE
- Target Recruit Count
- 100
- Registration Number
- NCT00910338
- Locations
- π°π·
Samsung Medical Center, Irwon-dong, Korea, Republic of
π°π·Asan Medical Center, Ulsan College of Medicine, Seoul, Korea, Republic of
A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- KYU-SUNG LEE
- Target Recruit Count
- 307
- Registration Number
- NCT00884104
Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- KYU-SUNG LEE
- Target Recruit Count
- 173
- Registration Number
- NCT00730535
- Locations
- π°π·
Samsung Medical Center, Irwon-dong, Seoul, Korea, Republic of
π°π·Asan Medical Center, Ulsan College of Medicine, Seoul, Korea, Republic of
π°π·Seoul National University Hospital, Seoul, Korea, Republic of
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
Phase 4
Completed
- Conditions
- Urinary Bladder, Overactive
- Interventions
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- KYU-SUNG LEE
- Target Recruit Count
- 94
- Registration Number
- NCT00699049
Β© Copyright 2025. All Rights Reserved by MedPath